Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
George Town, Grand Cayman, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Theravance Biopharma, Inc. has filed 1,125 SEC EDGAR filings since 01 Aug 2013

SEC filing history

Showing 551-575 of 1,000 matching filings.

Per page
25
Current page
23
4

FORM 4 -

Filing date
24 Feb 2020
Reporting date
20 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Feb 2020
Reporting date
20 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Feb 2020
Reporting date
20 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88552

AMENDMENT NO. 4 TO SC 13D

Filing date
18 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-235339

424B5

Filing date
12 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88552

SCHEDULE 13G/A

Filing date
12 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-235339

424B5

Filing date
10 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88552

SC 13G/A filing

Filing date
07 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88552

SC 13G/A filing

Filing date
06 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88552

SEC SCHEDULE 13G

Filing date
28 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .